| Trial ID: | L0243 |
| Source ID: | NCT03640026
|
| Associated Drug: |
Tacrolimus
|
| Title: |
Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients
|
| Acronym: |
GLITTER
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic
|
| Interventions: |
DRUG: Tacrolimus
|
| Outcome Measures: |
Primary: Proportion of haemodialysis patients modifying their glycemic profile receiving Tacrolimus, During 14 days |
|
| Sponsor/Collaborators: |
Sponsor: Centre Hospitalier Departemental Vendee
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2019-03-08
|
| Completion Date: |
2026-07
|
| Results First Posted: |
|
| Last Update Posted: |
2025-04-03
|
| Locations: |
Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France|Centre Hospitalier Universitaire Nantes, Nantes, France
|
| URL: |
https://clinicaltrials.gov/show/NCT03640026
|
